These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8719522)

  • 1. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.
    Fouts TR; Tuskan RG; Chada S; Hone DM; Lewis GK
    Vaccine; 1995 Dec; 13(17):1697-705. PubMed ID: 8719522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.
    Fouts TR; Lewis GK; Hone DM
    Vaccine; 1995 Apr; 13(6):561-9. PubMed ID: 7483777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.
    Berggren RE; Wunderlich A; Ziegler E; Schleicher M; Duke RC; Looney D; Fang FC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):489-95. PubMed ID: 8548327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.
    Buffa V; Negri DRM; Leone P; Bona R; Borghi M; Bacigalupo I; Carlei D; Sgadari C; Ensoli B; Cara A
    J Gen Virol; 2006 Jun; 87(Pt 6):1625-1634. PubMed ID: 16690927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV env immunities elicited by nucleic acid vaccines.
    Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
    Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector.
    Wu S; Pascual DW; Lewis GK; Hone DM
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1187-94. PubMed ID: 9310285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
    Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.
    Hone DM; Wu S; Powell RJ; Pascual DW; Van Cott J; McGhee J; Fouts TR; Tuskan RG; Lewis GK
    J Biotechnol; 1996 Jan; 44(1-3):203-7. PubMed ID: 8717405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.
    Newman MJ; Wu JY; Gardner BH; Anderson CA; Kensil CR; Recchia J; Coughlin RT; Powell MF
    Vaccine; 1997 Jun; 15(9):1001-7. PubMed ID: 9261947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant bacterial vaccine strain expressing dual viral antigens induces multiple immune responses to the Gag and gp120 proteins of HIV-1 in immunized mice.
    Feng Y; Wang S; Luo F; Ruan Y; Kang L; Xiang X; Chao T; Peng G; Zhu C; Mu Y; Zhu Y; Zhang X; Wu J
    Antiviral Res; 2008 Dec; 80(3):272-9. PubMed ID: 18639586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response in oral and rectal immunization by the attenuated strain of salmonella carrying the HIV DNA-vaccine].
    Karpenko LI; Nekrasova NA; Ignat'ev GM; Agafonov AP; Proniaeva TP; Murashev BV; Romanovich AE; Klimov NA; Kozlov AP; Il'ichev AA
    Vopr Virusol; 2003; 48(4):16-20. PubMed ID: 12945201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.
    Shiver JW; Perry HC; Davies ME; Freed DC; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():198-208. PubMed ID: 8546393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine.
    Hone DM; Lewis GK; Beier M; Harris A; McDaniels T; Fouts TR
    Dev Biol Stand; 1994; 82():159-62. PubMed ID: 7958470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team
    J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
    Evans TG; Keefer MC; Weinhold KJ; Wolff M; Montefiori D; Gorse GJ; Graham BS; McElrath MJ; Clements-Mann ML; Mulligan MJ; Fast P; Walker MC; Excler JL; Duliege AM; Tartaglia J
    J Infect Dis; 1999 Aug; 180(2):290-8. PubMed ID: 10395842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.
    Gorse GJ; Patel GB; Mandava MD; Arbuckle JA; Doyle TM; Belshe RB;
    Vaccine; 2001 Feb; 19(13-14):1806-19. PubMed ID: 11166906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
    Fuller DH; Haynes JR
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.